文献速递神经肿瘤小儿神经外科与脑积水

长链非编码RNA lnc-HLX-2-7在3型髓母细胞瘤中具有致癌作用

The long noncoding RNA lnc-HLX-2-7 is oncogenic in Group 3 medulloblastomas.
PubMed 文献 · Neuro Oncol · 2021-01-01

该研究通过分析175例髓母细胞瘤患者的RNA测序数据,鉴定出新型长链非编码RNA lnc-HLX-2-7在3型髓母细胞瘤中高表达。体外和体内实验表明,敲除lnc-HLX-2-7可抑制细胞增殖、3D集落形成并诱导凋亡,且小鼠颅内注射敲除细胞后形成的肿瘤更小。MYC癌基因调控lnc-HLX-2-7,BET溴结构域抑制剂JQ1可降低其表达,提示lnc-HLX-2-7是3型髓母细胞瘤的潜在分子标志物和治疗靶点。

要点

  • lnc-HLX-2-7在3型髓母细胞瘤中高表达,可作为潜在分子标志物。
  • 敲除lnc-HLX-2-7抑制增殖、集落形成并诱导凋亡,体内肿瘤更小。
  • MYC调控lnc-HLX-2-7,JQ1可降低其表达,提示治疗潜力。

核心结论

  • lnc-HLX-2-7在髓母细胞瘤中具有致癌作用,是3型髓母细胞瘤有前景的新型分子标志物和潜在治疗靶点。

研究设计与样本

  • 研究利用175例髓母细胞瘤患者的公开RNA测序数据鉴定区分亚型的长链非编码RNA。
  • 在体外和体内表征差异表达lncRNA后,用CRISPR/Cas9在髓母细胞瘤细胞系中敲除lnc-HLX-2-7。
  • 对颅内注射肿瘤进行批量及单细胞RNA测序进一步表征。

主要发现

  • 定量实时PCR、RNA测序和RNA荧光原位杂交显示,lnc-HLX-2-7在3型髓母细胞瘤细胞系、患者来源异种移植瘤和原发肿瘤中较其他亚型高表达。
  • 敲除lnc-HLX-2-7显著降低细胞增殖和3D集落形成并诱导凋亡。
  • 敲除lnc-HLX-2-7的细胞注射入小鼠小脑后形成的肿瘤较亲本细胞更小。
  • 通路分析显示lnc-HLX-2-7调控氧化磷酸化、线粒体功能障碍和sirtuin信号通路。
  • MYC癌基因调控lnc-HLX-2-7,小分子BET溴结构域家族-溴结构域4抑制剂JQ1降低lnc-HLX-2-7表达。

临床怎么用

  • lnc-HLX-2-7可作为3型髓母细胞瘤的潜在分子标志物用于亚型识别。
  • 靶向lnc-HLX-2-7或使用JQ1抑制其表达可能成为3型髓母细胞瘤的治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Medulloblastoma (MB) is an aggressive brain tumor that predominantly affects children. Recent high-throughput sequencing studies suggest that the noncoding RNA genome, in particular long noncoding RNAs (lncRNAs), contributes to MB subgrouping. Here we report the identification of a novel lncRNA, lnc-HLX-2-7, as a potential molecular marker and therapeutic target in Group 3 MBs. METHODS: Publicly available RNA sequencing (RNA-seq) data from 175 MB patients were interrogated to identify lncRNAs that differentiate between MB subgroups. After characterizing a subset of differentially expressed lncRNAs in vitro and in vivo, lnc-HLX-2-7 was deleted by CRISPR/Cas9 in the MB cell line. Intracranial injected tumors were further characterized by bulk and single-cell RNA-seq. RESULTS: Lnc-HLX-2-7 is highly upregulated in Group 3 MB cell lines, patient-derived xenografts, and primary MBs compared with other MB subgroups as assessed by quantitative real-time, RNA-seq, and RNA fluorescence in situ hybridization. Depletion of lnc-HLX-2-7 significantly reduced cell proliferation and 3D colony formation and induced apoptosis. Lnc-HLX-2-7-deleted cells injected into mouse cerebellums produced smaller tumors than those derived from parental cells. Pathway analysis revealed that lnc-HLX-2-7 modulated oxidative phosphorylation, mitochondrial dysfunction, and sirtuin signaling pathways. The MYC oncogene regulated lnc-HLX-2-7, and the small-molecule bromodomain and extraterminal domain family‒bromodomain 4 inhibitor Jun Qi 1 (JQ1) reduced lnc-HLX-2-7 expression. CONCLUSIONS: Lnc-HLX-2-7 is oncogenic in MB and represents a promising novel molecular marker and a potential therapeutic target in Group 3 MBs.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Katsushima K, Lee B, Kunhiraman H, et al. The long noncoding RNA lnc-HLX-2-7 is oncogenic in Group 3 medulloblastomas. Neuro Oncol. 2021. PMID: 33844835. doi:10.1093/neuonc/noaa235

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。